• US
  • China
  • France
  • DACH
  • Italy
  • Japan
  • UK
  • JMP
  • JMP Software
    • JMP
    • JMP Graph Builder for the iPad
    • JMP Pro
    • JMP Clinical
    • JMP Genomics
    • Free Trial
    • Buy JMP
    • About Us
  • Using JMP
    • Customer Stories
    • Application Areas
    • White Papers
    • Industries
    • Capabilities
    • Academic
  • News and Events
    • Seminars
    • Webcasts
    • Users Groups
    • Conferences
    • JMP in the News
    • JMP Blog
  • Resources for Users
    • JMP User Community
    • Support
    • Training
    • Learning Library
    • JMP Blog
    • File Exchange
    • Discussion Forum
    • JMP for Life Sciences Resource Center
    • Users Groups
    • Newsletters
  • Biotechnology
  • Chemicals & Plastics
  • Government
  • Manufacturing
  • Oil and Gas
  • Pharmaceuticals
    • Discovery Research
    • Pre-Clinical Development
    • Clinical Development
    • Post-Marketing Programs
  • Semiconductor
Image of Pills

Pharmaceuticals — Post-Marketing Programs

Substantiate the product safety and efficacy in large heterogeneous patient populations. JMP provides a range of capabilities for tracking a pharmaceutical product after its release to the market, from managing and analyzing a comprehensive database of monitored adverse events to communicating findings to appropriate parties through visual representations.

Benefits

Develop models to predict sub-populations most at risk for adverse events.

Utilize recursive partitioning methods to find hidden patterns in your data and identify sets of predictors that differentiate clusters of high-risk patients.

Leverage pharmaceutical receipt data to effectively target physicians.

JMP for Drug Discovery

The JMP product family offers interactive analysis for every stage of the drug discovery and development process

Discovery Research

Pre-Clinical Development

Clinical Development

Post-Marketing Programs


Featured Success Story

Kaiser Permanente

Kaiser Permanente
JMP® software plays an essential role in developing predictive models aimed at preventing mortality and morbidity in newborns and other patients.

Read the story

SAS | JMP is a business unit of SAS.

  • Terms of Use
  • Privacy Policy
  • Site Map
  • Contact